Thomas Trimarchi
President and CFO, BridgeBio Pharma, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$3.0M
Companies
1
Latest trade
May 18, 2026
Companies
BridgeBio Pharma, Inc.President and CFO −$3.0MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.
